AbCellera Biologics share price logo

AbCellera Biologics

NASDAQ: ABCL

Mid Cap

$11.35

-1.05

(-8.47%)

as on

AbCellera Biologics Stock Performance

as on August 29, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $11.26
    $12.35
    downward going graph

    0.79%

    Downside

    8.81%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.75
    $12.58
    downward going graph

    75.81%

    Downside

    10.84%

    Upside

    downward going graph

AbCellera Biologics share price movements today

Previous Close
$12.40
Open
$12.26
Volume
6.0M
Market Cap
$4.0B
Day's Low - High
$11.26 - $12.35
52 Week Low - High
$2.75 - $12.58

AbCellera Biologics Historical Returns

1 Month Return
+ 134.4 %
3 Month Return
+ 116.4 %
1 Year Return
+ 188.37 %
3 Year Return
+ 125.45 %
5 Year Return
-29.47 %

AbCellera Biologics Stock Fundamentals & Key Indicators

Check AbCellera Biologics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.0B

EPS (TTM)

-0.656

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.46%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-200.0M

Revenue (TTM)

66.2M

Profit Margin

-248.84%

Return On Equity TTM

-17.30%

AbCellera Biologics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of AbCellera Biologics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$4.0B-29.47%NA-248.84%NA
BUY$46.2B675.69%NA0.00%NA
BUY$138.7B173.88%31.9286.04%NA
BUY$59.7B-62.65%-7.98-12.57%NA
BUY$85.8B21.77%19.984.86%0.44%

Stock Returns calculator for AbCellera Biologics Stock including INR - Dollar returns

The AbCellera Biologics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

AbCellera Biologics investment value today

Current value as on today

₹2,86,086

Returns

₹1,86,086

(+186.09%)

Returns from AbCellera Biologics Stock

₹1,63,953 (+163.95%)

Dollar Impact

₹22,133 (+22.13%)

Analyst Recommendation on AbCellera Biologics Stock

Based on 7 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 7 analysts, 100% of analysts recommend a 'BUY' rating for AbCellera Biologics. Average target price of $17.12

AbCellera Biologics Share Price Target

Get share price movements and forecasts by analysts on AbCellera Biologics.

What analysts predicted

33.7%UPSIDE

Target Price

$17.12

Current Price

$11.35

Analyzed by

7 Analysts

Target

$17.12

AbCellera Biologics target price $17.12, a slight upside of 33.7% compared to current price of $11.35. According to 7 analysts rating.

Indian Investors' Interest in AbCellera Biologics Stock

Investment in AbCellera Biologics Shares on INDmoney has grown by 58.91% in the last 30 days, indicating increased investment activity.

Time period: to

Change:58.91% versus previous 30 day period

Search interest for AbCellera Biologics Stock has increased by 122% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:122% versus previous 30 day period

AbCellera Biologics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
9
7
6
5
4
17
8
44
8
4
Gross Profit
9
7
6
5
4
17
8
36
0
4
Operating Income
-54
-93
-93
-72
-62
-49
-76
-28
-57
-62
EBITDA
-44
-52
-51
-55
-51
-38
-66
-11
-40
-41
Interest Expense
-
-
-
-
8
-
-
16
-
0
Depreciation
6
38
38
13
6
7
7
7
8
8
Income Before Tax
-42
-48
-62
-46
-52
-36
-68
-19
-49
-58
Income Tax Expense
-2
-11
-11
-12
-7
-1
-11
-10
-6
-3
Net Income
-40
-36
-51
-34
-45
-34
-57
-8
-43
-55
Net Profit Margin
-407.98%
-504.30%
-785.42%
-677.43%
-1077.24%
-203.27%
-637.84%
-19.94%
-519.12%
-1368.57%

AbCellera Biologics Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
8
11
233
11
485
38
28
75
Gross Profit
8
11
206
11
418
38
28
46
Operating Income
0
-4
156
-4
216
-237
-314
-217
EBITDA
1
0
169
0
260
-192
-204
-148
Interest Expense
0
0
6
0
4
-
-
-
Depreciation
0
1
5
17
33
30
96
28
Income Before Tax
0
-2
157
-2
239
-174
-200
-177
Income Tax Expense
1
0
38
65
80
-27
-37
-31
Net Income
0
-2
118
-2
158
-146
-162
-146
Net Profit Margin
3.50%
-19.04%
51.00%
-19.04%
32.66%
-385.00%
-564.83%
-194.88%

AbCellera Biologics Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-36
-51
-34
-45
-34
-57
-8
-43
-98
Operating Cash Flow
-29
-28
-8
-11
-32
-52
-34
-33
-33
Investing Cash Flow
51
3
35
7
-31
36
75
-25
11
Financing Cash Flow
2
3
4
5
-3
7
4
7
13
Change in Cash
24
-21
29
2
-66
-9
44
-52
-7

AbCellera Biologics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-2
118
153
158
-146
-162
-146
Operating Cash Flow
2
22
244
277
-43
-108
-131
Investing Cash Flow
-5
-119
-332
-352
-221
121
87
Financing Cash Flow
0
683
-3
-1
10
12
14
Change in Cash
-2
586
-92
-86
-254
23
-28

Mutual Funds that own AbCellera Biologics Stock

Check out the Mutual Funds with significant holdings in AbCellera Biologics.

Funds
Holdings
Shares Held
SMALLCAP World Fund Inc
4.123192%
13361096
BlackRock Funds
0.105084%
340523
Driehaus Mutual Funds
0.076914%
249240
Fidelity Concord Street Trust
0.054609%
176961
LAZARD FUNDS INC
0.018044%
58472

Global Institutional Holdings in AbCellera Biologics

Funds
Holdings
Felix Baker
10.19%
iShares
0.97%
Richard Driehaus
0.88%
Counterpoint
0.35%
State Street
0.23%

Insights on AbCellera Biologics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ABCL stock has moved up by 99.5%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ABCL has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 472.8% return, outperforming this stock by 301.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 44.85M → 4.05M (in $), with an average decrease of 66.4% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -8.94M → -55.42M (in $), with an average decrease of 205.5% per quarter

About AbCellera Biologics

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc.; and Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
OrganisationAbCellera Biologics
Headquarters150 W 4th Avenue, Vancouver, BC, Canada, V5Y 1G6
IndustryBiotechnology
CEODr. Carl L.G. Hansen Ph.D.
E-voting on sharesClick here to vote

Key Management of AbCellera Biologics

Name

Title

Mr. Tryn T. Stimart Esq., J.D., M.Sc.

Chief Legal Officer, Chief Compliance Officer, Corporate Secretary & Privacy Officer

Mr. Andrew Knowles M.Sc.

Vice President of Operations

Marcie Thiessen CPA, CGA

Senior Director of Finance & Accounting

Mr. Martin Hogan M.Sc.

Senior Director of Strategic Finance & IR

Caitlin Webster CIPD, M.Sc.

Director of Talent Development

Dr. Veronique Lecault Ph.D.

CTO & Director

Mr. Andrew Booth M.B.A.

Chief Financial Officer

Ms. Tiffany Chiu B.Sc., Ph.D.

Vice President of Communications

Mr. Murray McCutcheon Ph.D.

Senior Vice President of Partnering

Dr. Carl L.G. Hansen Ph.D.

CEO, President & Chairperson

FAQs

What is AbCellera Biologics share price today?

AbCellera Biologics share price today is $11.35 as on at the close of the market. AbCellera Biologics share today touched a day high of $12.35 and a low of $11.26.

What is the 52 week high and 52 week low for AbCellera Biologics share?

AbCellera Biologics share touched a 52 week high of $12.58 on and a 52 week low of $2.75 on . AbCellera Biologics stock price today i.e. is closed at $11.35,which is 9.78% down from its 52 week high and 313.48% up from its 52 week low.

What is AbCellera Biologics's market capitalisation today?

AbCellera Biologics market capitalisation is $0.00T as on .

How to invest in AbCellera Biologics Stock (ABCL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for AbCellera Biologics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in AbCellera Biologics Shares that will get you 0.1322 shares as per AbCellera Biologics share price of $11.35 per share as on August 29, 2026 at 8:46 am IST.

What is the minimum amount required to buy AbCellera Biologics Stock (ABCL) from India?

Indian investors can start investing in AbCellera Biologics (ABCL) shares with as little as ₹95.38 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in AbCellera Biologics stock (as per the Rupee-Dollar exchange rate as on ). Based on AbCellera Biologics share’s latest price of $11.35 as on August 29, 2026 at 8:46 am IST, you will get 0.8811 shares of AbCellera Biologics. Learn more about fractional shares .

What are the returns that AbCellera Biologics has given to Indian investors in the last 5 years?

AbCellera Biologics stock has given -29.47% share price returns and 30.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?